Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.12.2 (
MEK
)
18,161
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have recently shown that the
histidine-rich calcium binding protein
(
HRC
) promotes the invasion and metastasis of hepatocellular carcinoma (HCC). In the current study, we evaluated whether
HRC
may also affect the growth of HCC. We found that ectopic expression of
HRC
obviously enhanced proliferation and colony formation, while suppression of
HRC
exhibited inhibitory effects. Furthermore, we demonstrated that
HRC
promoted tumor growth in nude mice. These effects may result from the ability of
HRC
to upregulate cyclinD1 and cyclin-dependent kinase 2 (CDK2) expressions and promote G1/S transition. Further study showed that
MEK
/ERK signaling pathway was involved in
HRC
-induced cell proliferation. Interestingly, overexpression or depletion of
HRC
revealed its regulation on endoplasmic reticulum stress (ERS) and apoptosis, which was partially dependent on PERK/ATF4/CHOP signaling pathway. In addition, blocking ERS using 4-phenylbutyric acid (4-PBA) not only downregulated the expression of PERK, ATF4 and CHOP, but also significantly decreased apoptosis induced by
HRC
silence, whereas ERS inducer thapsigargin (TG) exerted the opposite effects. Our study thus demonstrates a role of
HRC
in promoting HCC growth, besides its role in inducing HCC metastasis, and highlights
HRC
as a promising intervention target for HCC.
...
PMID:Histidine-rich calcium binding protein promotes growth of hepatocellular carcinoma in vitro and in vivo. 2617 91